Literature DB >> 1578043

The use of continuous atropine infusion in the management of severe tetanus.

D Dolar1.   

Abstract

Because previous studies assumed that tetanus is an acetylcholine intoxication, atropine as a potent anticholinergic agent has been employed as a continuous infusion in the treatment of 4 severe tetanus cases as a supplement to routine therapy. With this treatment all patients maintained complete cardiovascular stability; clinical symptoms like bronchospasm, bronchial hypersecretion, hypersalivation, hyperperspiration were not encountered at any period of the treatment. All patients were markedly sedated and despite the use of mechanical ventilation, curarisation was not necessary at all. These results suggest that the multiple effects (CNS, cardiovascular respiratory and muscular tone) of atropine might be very useful in the management of severe tetanus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1578043     DOI: 10.1007/bf01706422

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  32 in total

1.  Autonomic manifestations of tetanus.

Authors:  V M Hollow; G M Clarke
Journal:  Anaesth Intensive Care       Date:  1975-05       Impact factor: 1.669

2.  ACETYLCHOLINE LIBERATED FROM THE NERVE-MUSCLE PREPARATION IN TETANUS TOXIN POISONING.

Authors:  W FAL; L CZERCHAWSKI
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1963       Impact factor: 4.291

3.  Serum cholinesterase in tetanus.

Authors:  A Porath; M Acker; A Perel
Journal:  Anaesthesia       Date:  1977 Nov-Dec       Impact factor: 6.955

4.  Tetanus.

Authors:  J Macrae
Journal:  Br Med J       Date:  1973-03-24

5.  Oxime treatment in tetanus.

Authors:  G Leonardi
Journal:  Lancet       Date:  1971-09-18       Impact factor: 79.321

6.  Involvement of the sympathetic nervous system in tetanus. Studies on 82 cases.

Authors:  J H Kerr; J L Corbett; C Prys-Roberts; A C Smith; J M Spalding
Journal:  Lancet       Date:  1968-08-03       Impact factor: 79.321

7.  Severe sympathetic hyperactivity associated with tetanus.

Authors:  D J Kanarek; B Kaufman; S Zwi
Journal:  Arch Intern Med       Date:  1973-10

Review 8.  Pharmacology of tetanus.

Authors:  T P Bleck
Journal:  Clin Neuropharmacol       Date:  1986       Impact factor: 1.592

9.  Use of vecuronium in the management of tetanus.

Authors:  A B Powles; R Ganta
Journal:  Anaesthesia       Date:  1985-09       Impact factor: 6.955

10.  Morphine therapy controls autonomic hyperactivity in tetanus.

Authors:  M A Rie; R S Wilson
Journal:  Ann Intern Med       Date:  1978-05       Impact factor: 25.391

View more
  7 in total

Review 1.  Tetanus.

Authors:  J J Farrar; L M Yen; T Cook; N Fairweather; N Binh; J Parry; C M Parry
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

Review 2.  Post-neonatal tetanus: issues in intensive care management.

Authors:  S Singhi; V Jain; C Subramanian
Journal:  Indian J Pediatr       Date:  2001-03       Impact factor: 1.967

Review 3.  [Treatment strategies for tetanus].

Authors:  T Duning; W R Schäbitz
Journal:  Nervenarzt       Date:  2007-02       Impact factor: 1.214

4.  Tetanus.

Authors:  Sarice L. Bassin
Journal:  Curr Treat Options Neurol       Date:  2004-01       Impact factor: 3.598

5.  Use of intrathecal and intravenous clonidine in a case of severe tetanus with acute renal failure.

Authors:  Alok Kumar; Raktima Anand; Anita Rahal; Sandhya Od
Journal:  Indian J Anaesth       Date:  2009-04

Review 6.  Pharmacological management of tetanus: an evidence-based review.

Authors:  Chaturaka Rodrigo; Deepika Fernando; Senaka Rajapakse
Journal:  Crit Care       Date:  2014-03-26       Impact factor: 9.097

7.  Tetanus Complicated by Dysautonomia: A Case Report and Review of Management.

Authors:  Nishant Sharma; Si Li; Metlapalli Venkata Sravanthi; Dan Kazmierski; Yichen Wang; Amit Sharma; Pragya Dhaubhadel
Journal:  Case Rep Crit Care       Date:  2021-03-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.